{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:00:25Z","timestamp":1788012025657,"version":"build-2784847793"},"reference-count":13,"publisher":"Georg Thieme Verlag KG","issue":"05","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Medical School of University of P\u00e9cs, \"\u00c1OK-KA\" Research Program","award":["KA-2021-13"],"award-info":[{"award-number":["KA-2021-13"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropediatrics"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The mechanistic target of the rapamycin signaling pathway serves as a central regulator of cell metabolism, growth, proliferation, and survival. In its regulation, the GTPase-activating protein activity toward Rags1 complex has an inhibitory effect. Mutations in genes encoding this complex protein are among the most common abnormalities in focal epilepsies. Within these mutations, the mutations affecting the DEPDC5 gene have been associated with different autosomal dominantly inherited epilepsy types. Due to the limited data available on mTOR inhibitor therapy in nontuberous sclerosis complex epileptic patients, here we present the clinical management of a patient with intractable epilepsy, skin hypopigmentation, and a DEPDC5 variant. The patient's phenotype is compatible with a nonlesional DEPDC5-related epileptic encephalopathy. We initiated compassionate, off-label everolimus treatment as the patient's condition continuously deteriorated. Due to bilateral pneumonia occurring at the beginning of the treatment, it was temporarily discontinued, and resumed in half the dose. Follow-up examination after 18 months showed a 90% reduction in seizure frequency with moderate improvement in attention function and nutritional status. Our case report emphasizes the importance of early genetic testing in patients with epileptic encephalopathy. Clinical consequences of mammalian target of rapamycin complex 1 (mTORC1) upregulation may be amenable to tailored treatment with mTOR inhibitors. A clinical trial on an international scale would be needed to draw conclusions.<\/jats:p>","DOI":"10.1055\/a-2104-1614","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T23:03:22Z","timestamp":1685660602000},"page":"344-346","source":"Crossref","is-referenced-by-count":8,"title":["Observation of a Possible Successful Treatment of DEPDC5-Related Epilepsy with mTOR Inhibitor"],"prefix":"10.1055","volume":"54","author":[{"given":"Kinga","family":"Hadzsiev","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Medical School, Clinical Center, University of P\u00e9cs, P\u00e9cs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rta","family":"Hegyi","sequence":"additional","affiliation":[{"name":"Bethesda Children's Hospital, Epilepsy Center, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Fogarasi","sequence":"additional","affiliation":[{"name":"Bethesda Children's Hospital, Epilepsy Center, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00edmea","family":"Bod\u00f3-Baltav\u00e1ri","sequence":"additional","affiliation":[{"name":"Bethesda Children's Hospital, Epilepsy Center, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zsigmond","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Medical School, Clinical Center, University of P\u00e9cs, P\u00e9cs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Ma\u00e1sz","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Medical School, Clinical Center, University of P\u00e9cs, P\u00e9cs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Szab\u00f3","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Medical School, Clinical Center, University of P\u00e9cs, P\u00e9cs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4166-755X","authenticated-orcid":false,"given":"\u00c1gnes","family":"Till","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Medical School, Clinical Center, University of P\u00e9cs, P\u00e9cs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,7,30]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/epi.16370","article-title":"GATORopathies: the role of amino acid regulatory gene mutations in epilepsy and cortical malformations","volume":"60","author":"P H Iffland II","year":"2019","journal-title":"Epilepsia"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41436-018-0060-2","article-title":"The landscape of epilepsy-related GATOR1 variants","volume":"21","author":"S Baldassari","year":"2019","journal-title":"Genet Med"},{"issue":"08","key":"ref3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/jmedgenet-2016-103883","article-title":"GATOR1 complex: the common genetic actor in focal epilepsies","volume":"53","author":"S Baldassari","year":"2016","journal-title":"J Med Genet"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","volume":"74","author":"D A Krueger","year":"2013","journal-title":"Ann Neurol"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/aps.2015.68","article-title":"Toward rapamycin analog (rapalog)-based precision cancer therapy","volume":"36","author":"L H Meng","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"182ra53","DOI":"10.1126\/scitranslmed.3005271","article-title":"Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder","volume":"5","author":"W E Parker","year":"2013","journal-title":"Sci Transl Med"},{"issue":"04","key":"ref7","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/epi.12946","article-title":"mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia","volume":"56","author":"L H Nguyen","year":"2015","journal-title":"Epilepsia"},{"issue":"05","key":"ref8","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.24126","article-title":"Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations","volume":"75","author":"I E Scheffer","year":"2014","journal-title":"Ann Neurol"},{"issue":"06","key":"ref9","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1172\/JCI99384","article-title":"Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia-associated epilepsy","volume":"128","author":"T Ribierre","year":"2018","journal-title":"J Clin Invest"},{"issue":"21","key":"ref10","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/WNL.0b013e3181e04325","article-title":"Biallelic TSC gene inactivation in tuberous sclerosis complex","volume":"74","author":"P B Crino","year":"2010","journal-title":"Neurology"},{"issue":"08","key":"ref11","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41436-021-01161-6","article-title":"Clinical spectrum of MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities","volume":"23","author":"V Carmignac","year":"2021","journal-title":"Genet Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"622510","DOI":"10.3389\/fneur.2020.622510","article-title":"Network for therapy in rare epilepsies (NETRE): lessons from the past 15 years","volume":"11","author":"C von St\u00fclpnagel","year":"2021","journal-title":"Front Neurol"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"104036","DOI":"10.1016\/j.ejmg.2020.104036","article-title":"Compassionate use of everolimus for refractory epilepsy in a patient with MTOR mosaic mutation","volume":"63","author":"N Hadouiri","year":"2020","journal-title":"Eur J Med Genet"}],"container-title":["Neuropediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2104-1614.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T23:17:04Z","timestamp":1695079024000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2104-1614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":13,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2023,9,18]]},"published-print":{"date-parts":[[2023,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2104-1614","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0174-304X","1439-1899"],"issn-type":[{"value":"0174-304X","type":"print"},{"value":"1439-1899","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6,1]]},"published":{"date-parts":[[2023,6,1]]}}}